Ginkgo Bioworks Holdings (DNA) Raw Materials (2021 - 2023)

Ginkgo Bioworks Holdings (DNA) reported Raw Materials of $905000.0 for Q2 2023, up 4.87% on a YoY basis from $863000.0 in Q2 2022, and down 59.94% quarter-over-quarter from $2.3 million in Q1 2023.

Ginkgo Bioworks Holdings (DNA) Raw Materials (2021 - 2023) Analysis & Trends

Ginkgo Bioworks Holdings has reported Raw Materials for 3 years, with the latest figure at $905000.0 in Q2 2023.

  • For the quarter ending Q2 2023, Raw Materials rose 4.87% year-over-year to $905000.0; the trailing twelve-month figure through Jun 2023 stood at $905000.0 (up 4.87% YoY), and the FY2022 full-year result was $1.6 million, up 2384.38% from the prior year.
  • Raw Materials for Q2 2023 stood at $905000.0, down from $2.3 million in the prior quarter.
  • The five-year high for Raw Materials was $2.3 million in Q1 2023, with the low at $64000.0 in Q4 2021.
  • Historically, Raw Materials has averaged $1.1 million across 3 years, with a median of $884000.0 in 2022.
  • Annual changes were most pronounced in 2022 — Raw Materials soared 2384.38% — and 2023, when it climbed 4.87%.
  • Ginkgo Bioworks Holdings' Raw Materials stood at $64000.0 in 2021, then soared by 2384.38% to $1.6 million in 2022, then tumbled by 43.08% to $905000.0 in 2023.
  • The last three Raw Materials figures came in at $905000.0 (Q2 2023), $2.3 million (Q1 2023), and $1.6 million (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Ginkgo Bioworks Holdings 546.79 Mn 546.79 Mn 16.38 Mn

Historic Data

Download Data
DateValue
Jun 30, 2023 905,000.00
Mar 31, 2023 2.26 Mn
Dec 31, 2022 1.59 Mn
Sep 30, 2022 1.28 Mn
Jun 30, 2022 863,000.00
Mar 31, 2022 799,000.00
Dec 31, 2021 64,000.00
Sep 30, 2021 828,000.00